Skip to main content

Advertisement

SpringerLink
Log in

Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

A well-characterized 69.5×103 dalton glycoprotein fetal antigen (FA), isolated from the spent culture medium of a melanoma cell line, UCLA-SO-14 (M14), was utilized to characterize the antigen component of circulating immune complexes (CIC) from melanoma patients. Ten serum samples from five patients with stage II melanoma at 1 and 4 months prior to the clinical detection of recurrent disease were selected for study. The CIC were dissociated with low pH and ultrafiltered through a 100¢103 dalton exclusion limit membrane. The low pH treatment resulted in an increase in antibody titer in eight of ten serum samples. The antibody activity in membrane immunofluorescence was quantitatively inhibited by the filtered antigen fraction and purified FA, suggesting the presence of anti-FA antibodies in the treated serum, which possibly were complexed with FA in the untreated sample. As determined by competitive inhibition in an enzyme-linked immunosorbent assay, the filtrate (antigen fraction) contained an antigen that was immunologically similar to FA. These results clearly demonstrate that FA, expressed on the cell surface of melanoma cells, is present in CIC of selected melanoma patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brystryn JC (1971) Release of cell surface tumor-associated antigens by viable melanoma cells from human. J Natl Cancer Inst 59:325

    Google Scholar 

  2. Ceriani RL, Sasaki M, Sussman M, Wara WM, Blank EW (1980) Circulating human mammary epithelial antigen in breast cancer. Proc Natl Acad Sci USA 79:5420

    Google Scholar 

  3. Chee DO, Boddie AW, Roth JA, Holmes EC, Morton DL (1983) Production of melanoma associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium. Cancer Res 36:1503

    Google Scholar 

  4. Cronin WJ, Dorsett BH, Ioachim HL (1982) Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera. Cancer Res 42:292

    Google Scholar 

  5. Day NK, Winfifield JB, Gee R, Winchester RJ, Teshina H, Kunkel HG (1978) Evidence for immune complexes involved in antilymphocyte antibodies associated with hypocomplementemia in chronic leukemia (CLL). Clin Exp Immunol 26:189

    Google Scholar 

  6. Dorvall G, Pross H (1985) Immune complexes in cancer. In: Espinosa C, Osterland C (eds) Circulating immune complexes. Futura, New York, p 55

    Google Scholar 

  7. Grimm EA, Silver HKB, Roth JA et al. (1976) Detection of tumor-associated antigen in human melanoma cell line supernatants. Int J Cancer 17:559

    Google Scholar 

  8. Gupta RK, Morton DL (1980) Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line. J Natl Cancer Inst 70:991

    Google Scholar 

  9. Gupta RK, Morton DL (1984) Studies of melanoma tumor associated antigen detected in the spent culture medium of a human melanoma cell line by allogenic antibody. I. Purification and development of a radioimmunoassay. J Natl Cancer Inst 72:67

    Google Scholar 

  10. Gupta RK, Irie RK, Chee DO, Kern DH, Morton DL (1978) Antigens in spent serum free medium of a human melanoma cell line. Bacteriol Proc 79:54

    Google Scholar 

  11. Gupta RK, Golub SH, Morton DL (1979) Correlation between tumor burden and anti-complementary activity in sera from patients. Cancer Immunol Immunother 6:21

    Google Scholar 

  12. Gupta RK, Irie RK, Chee DO, Kern DH, Morton DL (1979) Demonstration of distinct antigens in spent tissue culture medium of a human malignant melanoma cell line. J Natl Cancer Inst 63:337

    Google Scholar 

  13. Gupta RK, Leitch AM, Morton DL (1980) Nature of antigens and antibodies in immune complexes isolated by staphlycoccal protein A from plasma of melanoma patients. Cancer Immunol Immunother 16:40

    Google Scholar 

  14. Kirkwood JIM, Vlock DR (1984) Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum. Cancer Res 44:4177

    Google Scholar 

  15. Koprowski H, Herlyn D, Lubeck M, DeFreitas E, Sears F (1984) Human antiidiotype antibodies in cancer patients: Is the modulation of immune response beneficial for the patient? Proc Natl Acad Sci USA 81:216

    Google Scholar 

  16. Kristensen E, Branslund I, Nielson H, Svehag SE (1980) Prognostic value of assay for circulating immune complexes and natural cytotoxicity in malignant skin melanoma (stage I and II). Cancer Immunol Immunother 9:31

    Google Scholar 

  17. Lachmann PJ, Macanovic M, Harkin GD, Oldroyd RG, Habicht J (1981) The isolation of the antibody moieties of immune complexes from serum by pepsin digestion and conglutinin-anti-conglutinin complexes. Clin Exp Immunol 46:250

    Google Scholar 

  18. Lewis CM, Pegbgrum GD (1978) Autoimmune antibodies in chronic lymphatic leukemia. Br J Haemotol 38:75

    Google Scholar 

  19. Lutz PM, Dawson JR (1981) Activity of antibody preparations from immune complexes of ovarian cancer patients. Fed Proc 40:118

    Google Scholar 

  20. Maidment BW, Papsidero LD, Neomoto T Chu TM (1981) Recovery of immunologically reactive antibodies and antigens from breast cancer immune complexes by preparation isoelectric focusing. Cancer Res 41:795

    Google Scholar 

  21. Moller G (1961) Demonstration of mouse isoantigens at the cellular level by the fluorescent antibody technique. J Exp Med 114:415

    Google Scholar 

  22. Mukojima T, Guerven P, Klein G (1973) Circulating antigen-antibody complexes associated with Epstein-Barr virus in recurrent Burkitt's lymphoma. J Natl Cancer Inst 51:1319

    Google Scholar 

  23. Philips TM, Queen WD, Lewis MG (1982) The significance of circulating immune complexes in patients with malignant melanoma. In: Reisfeld RA, Ferrone S (eds) Melanoma antigens and antibodies. Plenum Press, New York, p 289

    Google Scholar 

  24. Price MR, Robins RA (1978) Circulating factors modifying cell mediated immunity in experimental neoplasia. In: Castor JE (ed) Immunologic aspects of cancer. University Park Press, Baltimore, p 155

    Google Scholar 

  25. Ruell P, Murray E, McCarthy WH, Hersey P (1982) Evaluation of assay to detect immune complexes as an immunodiagnostic aid in patients with melanoma. Oncodevelop Biol Med 3:1

    Google Scholar 

  26. Salina FA, Wee KH, Silver HKB (1980) Detection and characterization of antibodies to xenogeneic oncofetal antigen (XOFA) in human neoplasia. In: Rosenberg SA (ed) Serologic analysis of human cancer antigen. Academic Press, New York, p 539

    Google Scholar 

  27. Salina FA, Wee KH, Silver HKB (1983) Immune complexes and human neoplasia. Review II. Biomed Pharmacother 37:119

    Google Scholar 

  28. Salina FA, Wee KH, Silver HKB (1985) Clinical relevance of immune complexes, associated antigen, and antibody in cancer. In: Salinas FA, Hanna Jr HG (eds) Immune complexes and human cancer. Plenium Press, New York, p 55

    Google Scholar 

  29. Schupbach J, Kalyanaraman VS, Sarngadharan MG, Gunn BA, Blayney DW, Gallo RC (1984) Demonstration of viral antigen P-24 in circulating immune complexes of two patients with human T cell leukemia/lymphoma virus (HTLV) positive lymphoma Lancet I:302

    Google Scholar 

  30. Sjogren HO, Hellstrom I, Bansal SC, Hellstrom KE (1971) Suggestive evidence that the “blocking antibodies” of tumor bearing individuals may be antigen-antibody complexes. Proc Natl Acad Sci USA 68:1372

    Google Scholar 

  31. Wong JH, Gupta RK, Morton DL (1986) Serial determinations of melanoma tumor-associated antibody and antigen in patients with stage I melanoma. Arch Surg 121:132

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Oncology, John Wayne Cancer Clinic, Jonsson Comprehensive Cancer Center, UCLA School of Medicine, 90024, Los Angeles, CA, USA

    Jan H. Wong, Bibi Augero, Rishab K. Gupta & Donald L. Morton

  2. Sepulveda Veteran Administration Medical Center, Sepulveda, California, USA

    Jan H. Wong

Authors
  1. Jan H. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bibi Augero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rishab K. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Donald L. Morton
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by NIH grants CA 30019, CA 12582, CA 09010, CA 29605 awarded by DHSS

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, J.H., Augero, B., Gupta, R.K. et al. Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients. Cancer Immunol Immunother 27, 142–146 (1988). https://doi.org/10.1007/BF00200019

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00200019

Keywords

Search

Navigation